期刊
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
卷 6, 期 4, 页码 249-268出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1756285613478870
关键词
demyelinating disease; multiple sclerosis; MRI; neuroimaging
资金
- NIH [R01 NS 58698]
- Mayo Clinic Intramural Funds
- CTSA from the National Center for Advancing Translational Science (NCATS) [UL1 TR000135]
Central nervous system inflammatory demyelinating disease can affect patients across the life span. Consensus definitions and criteria of all of the different acquired demyelinating diseases that fall on this spectrum have magnetic resonance imaging criteria. The advances of both neuroimaging techniques and important discoveries in immunology have produced an improved understanding of these conditions and classification. Neuroimaging plays a central role in the accurate diagnosis, prognosis, disease monitoring and research efforts that are being undertaken in this disease. This review focuses on the imaging spectrum of acquired demyelinating disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据